Advanced Enzyme (India) Performance
| ADVENZYMES | 306.30 5.80 1.86% |
Advanced Enzyme has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0208, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Advanced Enzyme's returns are expected to increase less than the market. However, during the bear market, the loss of holding Advanced Enzyme is expected to be smaller as well. Advanced Enzyme Tech right now shows a risk of 2.44%. Please confirm Advanced Enzyme Tech skewness, and the relationship between the value at risk and day median price , to decide if Advanced Enzyme Tech will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Advanced Enzyme Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Advanced Enzyme may actually be approaching a critical reversion point that can send shares even higher in September 2025. ...more
Forward Dividend Yield 0.0167 | Payout Ratio 0.9075 | Last Split Factor 5:1 | Forward Dividend Rate 5.2 | Ex Dividend Date 2025-07-23 |
1 | Advanced Enzyme Technologies Shows Mixed Technical Trends Amid Market Evaluation Changes - MarketsMojo | 06/13/2025 |
2 | Advanced Enzyme Technologies Dividend Will Be 1.20 - simplywall.st | 06/27/2025 |
3 | Advanced Enzyme Technologies Limited Stock Experiences Sudden Dip - Over 200 percent growth - Autocar Professional | 07/23/2025 |
4 | 10 healthcare stocks post over 10 percent sales profit growth in June quarter rally in FY26 - The Economic Times | 08/06/2025 |
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | -990.4 M |
Advanced |
Advanced Enzyme Relative Risk vs. Return Landscape
If you would invest 28,728 in Advanced Enzyme Technologies on May 25, 2025 and sell it today you would earn a total of 1,902 from holding Advanced Enzyme Technologies or generate 6.62% return on investment over 90 days. Advanced Enzyme Technologies is generating 0.1297% of daily returns and assumes 2.4424% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Advanced, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Advanced Enzyme Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Enzyme's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Advanced Enzyme Technologies, and traders can use it to determine the average amount a Advanced Enzyme's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0531
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ADVENZYMES | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Advanced Enzyme is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Advanced Enzyme by adding it to a well-diversified portfolio.
Advanced Enzyme Fundamentals Growth
Advanced Stock prices reflect investors' perceptions of the future prospects and financial health of Advanced Enzyme, and Advanced Enzyme fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Advanced Stock performance.
| Return On Equity | 0.0944 | ||||
| Return On Asset | 0.0626 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 29.19 B | ||||
| Shares Outstanding | 111.88 M | ||||
| Price To Book | 2.45 X | ||||
| Price To Sales | 5.22 X | ||||
| Revenue | 6.37 B | ||||
| Gross Profit | 4.87 B | ||||
| EBITDA | 2.27 B | ||||
| Net Income | 1.31 B | ||||
| Cash And Equivalents | 667.5 M | ||||
| Total Debt | 393.5 M | ||||
| Book Value Per Share | 127.00 X | ||||
| Cash Flow From Operations | 1.49 B | ||||
| Earnings Per Share | 12.24 X | ||||
| Total Asset | 16.21 B | ||||
| Retained Earnings | 11.53 B | ||||
About Advanced Enzyme Performance
Evaluating Advanced Enzyme's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Advanced Enzyme has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Advanced Enzyme has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Advanced Enzyme is entity of India. It is traded as Stock on NSE exchange.Things to note about Advanced Enzyme Tech performance evaluation
Checking the ongoing alerts about Advanced Enzyme for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Advanced Enzyme Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 56.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: 10 healthcare stocks post over 10 percent sales profit growth in June quarter rally in FY26 - The Economic Times |
- Analyzing Advanced Enzyme's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Advanced Enzyme's stock is overvalued or undervalued compared to its peers.
- Examining Advanced Enzyme's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Advanced Enzyme's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Advanced Enzyme's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Advanced Enzyme's stock. These opinions can provide insight into Advanced Enzyme's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Advanced Stock Analysis
When running Advanced Enzyme's price analysis, check to measure Advanced Enzyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Enzyme is operating at the current time. Most of Advanced Enzyme's value examination focuses on studying past and present price action to predict the probability of Advanced Enzyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Enzyme's price. Additionally, you may evaluate how the addition of Advanced Enzyme to your portfolios can decrease your overall portfolio volatility.